Cargando…

Glycines from the APP GXXXG/GXXXA Transmembrane Motifs Promote Formation of Pathogenic Aβ Oligomers in Cells

Alzheimer’s disease (AD) is the most common neurodegenerative disorder characterized by progressive cognitive decline leading to dementia. The amyloid precursor protein (APP) is a ubiquitous type I transmembrane (TM) protein sequentially processed to generate the β-amyloid peptide (Aβ), the major co...

Descripción completa

Detalles Bibliográficos
Autores principales: Decock, Marie, Stanga, Serena, Octave, Jean-Noël, Dewachter, Ilse, Smith, Steven O., Constantinescu, Stefan N., Kienlen-Campard, Pascal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4861705/
https://www.ncbi.nlm.nih.gov/pubmed/27242518
http://dx.doi.org/10.3389/fnagi.2016.00107
_version_ 1782431238220414976
author Decock, Marie
Stanga, Serena
Octave, Jean-Noël
Dewachter, Ilse
Smith, Steven O.
Constantinescu, Stefan N.
Kienlen-Campard, Pascal
author_facet Decock, Marie
Stanga, Serena
Octave, Jean-Noël
Dewachter, Ilse
Smith, Steven O.
Constantinescu, Stefan N.
Kienlen-Campard, Pascal
author_sort Decock, Marie
collection PubMed
description Alzheimer’s disease (AD) is the most common neurodegenerative disorder characterized by progressive cognitive decline leading to dementia. The amyloid precursor protein (APP) is a ubiquitous type I transmembrane (TM) protein sequentially processed to generate the β-amyloid peptide (Aβ), the major constituent of senile plaques that are typical AD lesions. There is a growing body of evidence that soluble Aβ oligomers correlate with clinical symptoms associated with the disease. The Aβ sequence begins in the extracellular juxtamembrane region of APP and includes roughly half of the TM domain. This region contains GXXXG and GXXXA motifs, which are critical for both TM protein interactions and fibrillogenic properties of peptides derived from TM α-helices. Glycine-to-leucine mutations of these motifs were previously shown to affect APP processing and Aβ production in cells. However, the detailed contribution of these motifs to APP dimerization, their relation to processing, and the conformational changes they can induce within Aβ species remains undefined. Here, we describe highly resistant Aβ42 oligomers that are produced in cellular membrane compartments. They are formed in cells by processing of the APP amyloidogenic C-terminal fragment (C99), or by direct expression of a peptide corresponding to Aβ42, but not to Aβ40. By a point-mutation approach, we demonstrate that glycine-to-leucine mutations in the G(29)XXXG(33) and G(38)XXXA(42) motifs dramatically affect the Aβ oligomerization process. G33 and G38 in these motifs are specifically involved in Aβ oligomerization; the G33L mutation strongly promotes oligomerization, while G38L blocks it with a dominant effect on G33 residue modification. Finally, we report that the secreted Aβ42 oligomers display pathological properties consistent with their suggested role in AD, but do not induce toxicity in survival assays with neuronal cells. Exposure of neurons to these Aβ42 oligomers dramatically affects neuronal differentiation and, consequently, neuronal network maturation.
format Online
Article
Text
id pubmed-4861705
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-48617052016-05-30 Glycines from the APP GXXXG/GXXXA Transmembrane Motifs Promote Formation of Pathogenic Aβ Oligomers in Cells Decock, Marie Stanga, Serena Octave, Jean-Noël Dewachter, Ilse Smith, Steven O. Constantinescu, Stefan N. Kienlen-Campard, Pascal Front Aging Neurosci Neuroscience Alzheimer’s disease (AD) is the most common neurodegenerative disorder characterized by progressive cognitive decline leading to dementia. The amyloid precursor protein (APP) is a ubiquitous type I transmembrane (TM) protein sequentially processed to generate the β-amyloid peptide (Aβ), the major constituent of senile plaques that are typical AD lesions. There is a growing body of evidence that soluble Aβ oligomers correlate with clinical symptoms associated with the disease. The Aβ sequence begins in the extracellular juxtamembrane region of APP and includes roughly half of the TM domain. This region contains GXXXG and GXXXA motifs, which are critical for both TM protein interactions and fibrillogenic properties of peptides derived from TM α-helices. Glycine-to-leucine mutations of these motifs were previously shown to affect APP processing and Aβ production in cells. However, the detailed contribution of these motifs to APP dimerization, their relation to processing, and the conformational changes they can induce within Aβ species remains undefined. Here, we describe highly resistant Aβ42 oligomers that are produced in cellular membrane compartments. They are formed in cells by processing of the APP amyloidogenic C-terminal fragment (C99), or by direct expression of a peptide corresponding to Aβ42, but not to Aβ40. By a point-mutation approach, we demonstrate that glycine-to-leucine mutations in the G(29)XXXG(33) and G(38)XXXA(42) motifs dramatically affect the Aβ oligomerization process. G33 and G38 in these motifs are specifically involved in Aβ oligomerization; the G33L mutation strongly promotes oligomerization, while G38L blocks it with a dominant effect on G33 residue modification. Finally, we report that the secreted Aβ42 oligomers display pathological properties consistent with their suggested role in AD, but do not induce toxicity in survival assays with neuronal cells. Exposure of neurons to these Aβ42 oligomers dramatically affects neuronal differentiation and, consequently, neuronal network maturation. Frontiers Media S.A. 2016-05-10 /pmc/articles/PMC4861705/ /pubmed/27242518 http://dx.doi.org/10.3389/fnagi.2016.00107 Text en Copyright © 2016 Decock, Stanga, Octave, Dewachter, Smith, Constantinescu and Kienlen-Campard. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Decock, Marie
Stanga, Serena
Octave, Jean-Noël
Dewachter, Ilse
Smith, Steven O.
Constantinescu, Stefan N.
Kienlen-Campard, Pascal
Glycines from the APP GXXXG/GXXXA Transmembrane Motifs Promote Formation of Pathogenic Aβ Oligomers in Cells
title Glycines from the APP GXXXG/GXXXA Transmembrane Motifs Promote Formation of Pathogenic Aβ Oligomers in Cells
title_full Glycines from the APP GXXXG/GXXXA Transmembrane Motifs Promote Formation of Pathogenic Aβ Oligomers in Cells
title_fullStr Glycines from the APP GXXXG/GXXXA Transmembrane Motifs Promote Formation of Pathogenic Aβ Oligomers in Cells
title_full_unstemmed Glycines from the APP GXXXG/GXXXA Transmembrane Motifs Promote Formation of Pathogenic Aβ Oligomers in Cells
title_short Glycines from the APP GXXXG/GXXXA Transmembrane Motifs Promote Formation of Pathogenic Aβ Oligomers in Cells
title_sort glycines from the app gxxxg/gxxxa transmembrane motifs promote formation of pathogenic aβ oligomers in cells
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4861705/
https://www.ncbi.nlm.nih.gov/pubmed/27242518
http://dx.doi.org/10.3389/fnagi.2016.00107
work_keys_str_mv AT decockmarie glycinesfromtheappgxxxggxxxatransmembranemotifspromoteformationofpathogenicaboligomersincells
AT stangaserena glycinesfromtheappgxxxggxxxatransmembranemotifspromoteformationofpathogenicaboligomersincells
AT octavejeannoel glycinesfromtheappgxxxggxxxatransmembranemotifspromoteformationofpathogenicaboligomersincells
AT dewachterilse glycinesfromtheappgxxxggxxxatransmembranemotifspromoteformationofpathogenicaboligomersincells
AT smithsteveno glycinesfromtheappgxxxggxxxatransmembranemotifspromoteformationofpathogenicaboligomersincells
AT constantinescustefann glycinesfromtheappgxxxggxxxatransmembranemotifspromoteformationofpathogenicaboligomersincells
AT kienlencampardpascal glycinesfromtheappgxxxggxxxatransmembranemotifspromoteformationofpathogenicaboligomersincells